No proven treatment modality currently exists for the sequelae/long term effects of either mTBI with PTSD or PTSD.
Our vision is to administer the compounds of Psilocybin and NAC in certified drug and talk therapy clinics. As well, to ensure the use of treatment protocols and professionally trained personnel collaboratively appointed with our university research institute partners, consistent with the highest patient safety standards, reviewed and approved by pertinent regulators including the FDA.
Other than medicines that mask individual symptoms related to either condition, there are no effective drugs for these disorders. Our development effort can result in a ground breaking treatment for these conditions and represents a societal health and financial benefit with a tremendous upside potential for Eleusian’s stakeholders.